|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2008-8-11
|
|
pubmed:abstractText |
Intestinal Behçet disease (BD) is characterized by intestinal inflammation with round and oval ulcers associated with gastrointestinal symptoms. Although several cases have been reported that infliximab is effective for induction of remission, the efficacy of infliximab for maintaining remission is unknown.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1536-4844
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1259-64
|
|
pubmed:dateRevised |
2011-4-6
|
|
pubmed:meshHeading |
pubmed-meshheading:18393375-Adult,
pubmed-meshheading:18393375-Antibodies, Monoclonal,
pubmed-meshheading:18393375-Behcet Syndrome,
pubmed-meshheading:18393375-Colonoscopy,
pubmed-meshheading:18393375-Female,
pubmed-meshheading:18393375-Gastrointestinal Agents,
pubmed-meshheading:18393375-Humans,
pubmed-meshheading:18393375-Intestinal Diseases,
pubmed-meshheading:18393375-Male,
pubmed-meshheading:18393375-Middle Aged,
pubmed-meshheading:18393375-Remission Induction,
pubmed-meshheading:18393375-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Efficacy of infliximab for induction and maintenance of remission in intestinal Behçet's disease.
|
|
pubmed:affiliation |
Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan.
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
